Suchergebnisse - "Exemestane"

PubPharm (884)

1

Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept

enthalten in: Analytical and bioanalytical chemistry | 2024

von Jacobs, C. | Radosa, J. | Wagmann, L. | +8

2

Exemestane plus everolimus and palbociclib in metastatic breast cancer : clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

enthalten in: Nature communications | 2024

von Gómez Tejeda Zañudo, J. | Barroso-Sousa, R. | Jain, E. | +15

3

The effect of exemestane administration on the lipid profile in women : Meta-analysis of randomized controlled trials

enthalten in: European journal of obstetrics, gynecology, and reproductive biology | 2024

von Yang, L. | Xiang, Y. | Wu, S. | +3

4

p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane

enthalten in: British journal of cancer | 2024

von Vanacker, H. | Treilleux, I. | Schiffler, C. | +16

5

Resveratrol-Exemestane Beneficial Regimen to Overcome the Complications over Existing Therapies for the Management of Breast Cancer

enthalten in: Current molecular medicine | 2024

von Kaur, S. | Singh, D.

6

Incorporation of exemestane into ternary nanosponge system for enhanced anti-tumor potential in breast cancer

enthalten in: Pharmaceutical development and technology | 2023

von Mane, P. | Wakure, B. | Wakte, P.

7

Acute generalized exanthematous pustulosis induced by exemestane during adjuvant radiotherapy for breast cancer

enthalten in: Medicina clinica | 2023

von Ferini, G. | Zagardo, V. | Strazzanti, A.

CommentOn: Med Clin (Barc). 2021 Sep 10;157(5):260-261. - PMID 32843220

8

Lyophilized mixed micelles of exemestane : A novel paradigm to improve its absorption and anticancer activity

enthalten in: Archiv der Pharmazie | 2023

von Singh, G. | Kaur, P. | Singh, D. | +3

9

Development and Method Validation of Design of Experiments-Optimized Tablet Formulation for Simultaneous Detection of Exemestane and Everolimus

enthalten in: Assay and drug development technologies | 2023

von Kumar, A. | Kurmi, B. | Singh, D.

10

Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy : An extensive preclinical investigation

enthalten in: International journal of pharmaceutics | 2023

von Rizwanullah, M. | Perwez, A. | Alam, M. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[89]